Postoperative Pain Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Jun 2019| TMR1639A| Transparency

Report Highlights

Transparency Market Research (TMR) has recently published a research report on the postoperative pain therapeutics market for the forecast period of 2019-2027, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the postoperative pain therapeutics market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2027.

The research study on the postoperative pain therapeutics market analyzes key drivers upholding product sales and prominent trends shaping the growth of the postoperative pain therapeutics market. The research study not only focuses on the latent opportunities for the key stakeholders of the postoperative pain therapeutics market, but also sheds light on the notable developments and future scope for innovation in the postoperative pain therapeutics landscape.

The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study by TMR on the postoperative pain therapeutics market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the postoperative pain therapeutics market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

North America
Europe
Asia Pacific
Latin America
Middle East and Africa
The report also analyzes the postoperative pain therapeutics market on the basis of various segments, with drug type being a prominent one. A unique section in the postoperative pain therapeutics market report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred. The next section offers a quick view into the different types of distribution channels and their respective performances.

Postoperative Pain Therapeutics Market - Key Questions Answered in the Report

The report on the postoperative pain therapeutics market addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the postoperative pain therapeutics market report include-

What is the overall structure of the postoperative pain therapeutics market?
What was the historical value and what is the forecasted value of the postoperative pain therapeutics market?
What are the key product level trends in the postoperative pain therapeutics market?
What are the market level trends in the postoperative pain therapeutics market?
Which of the market players are leading and what are their key differential strategies to retain their stronghold?
Which are the most lucrative regions in the postoperative pain therapeutics market space?

Postoperative Pain Therapeutics Market - Research Methodology

The report on the postoperative pain therapeutics market is based on an extensive and meticulous bottom up approach, which was used to determine the market size. Total number of surgical procedures were mapped across countries and number of surgeries requiring postoperative pain management were analyzed and estimated.

In the primary phase of the research methodology for the postoperative pain therapeutics market, key stakeholders, including CEOs, presidents, vice presidents, chief medical officers, and product/sales/marketing managers were interviewed for the purpose of garnering unique insights into the dynamics of the postoperative pain therapeutics market. In addition, around 41% of the primary research and analysis was carried out with hospitals/specialty clinics, medical assistants, surgeons, physicians, and pharmacists.

For the secondary phase, prominent sources such as the American Society of Regional Anesthesia and Pain Medicine, American Academy of Pain Medicine, Chronic Pain Association of Canada, Center for Disease Control & Prevention (CDC), National Institutes of Health (NIH), and others were referred to for garnering authentic data with the highest credibility.

Some of the prominent players profiled in the postoperative pain therapeutics market report are-

Mallinckrodt Pharmaceuticals
Trevena, Inc.
Heron Therapeutics
Pacira BioSciences, Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lilly & Company
Mallinckrodt Pharmaceuticals
Bayer AG
Novartis AG
Camarus

  • Table 1 : Incidence (%) of Chronic Postoperative Pain
  • Table 2 : Pipeline Analysis
  • Table 3 : Principle difference between U.S., EU, and India
  • Table 4 : Regulatory Scenario Assessment - Administrative Requirements
  • Table 5 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class,2017-2027
  • Table 6 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 7 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 8 : Global Postoperative Pain Therapeutics Treatment Market Value (US$ Mn) Forecast, by Region,2017-2027
  • Table 9 : North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country,2017-2027
  • Table 10 : North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class,2017-2027
  • Table 11 : North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 12 : North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 13 : Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class,2017-2027
  • Table 14 : Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 15 : Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 16 : Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 17 : Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class,2017-2027
  • Table 18 : Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 19 : Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 20 : Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 21 : Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class,2017-2027
  • Table 22 : Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 23 : Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 24 : Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 25 : Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class,2017-2027
  • Table 26 : Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration,2017-2027
  • Table 27 : Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 28 : Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Figure 1 : Global Postoperative Pain Therapeutics Market Snapshot
  • Figure 2 : Regulatory Approval Process - U.S.
  • Figure 3 : Regulatory Approval Process - Europe
  • Figure 4 : Regulatory Approval Process - India
  • Figure 5 : Total Surgical Procedures requiring Postoperative Pain Management
  • Figure 6 : Global Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 7 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Opioids,2017-2027
  • Figure 8 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by NSAIDS,2017-2027
  • Figure 9 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Local Anesthetics,2017-2027
  • Figure 10 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Tricyclic Antidepressants,2017-2027
  • Figure 11 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Antiepileptic Drugs,2017-2027
  • Figure 12 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others,2017-2027
  • Figure 13 : Global Postoperative Pain Therapeutics Market Attractiveness, by Drug Class, 2019 - 2027
  • Figure 14 : Global Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 15 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oral,2017-2027
  • Figure 16 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intramuscular,2017-2027
  • Figure 17 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intravenous,2017-2027
  • Figure 18 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others,2017-2027
  • Figure 19 : Global Postoperative Pain Therapeutics Market Attractiveness, by Route of Administration, 2019 - 2027
  • Figure 20 : Global Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 21 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies,2017-2027
  • Figure 22 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies,2017-2027
  • Figure 23 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies,2017-2027
  • Figure 24 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others,2017-2027
  • Figure 25 : Global Postoperative Pain Therapeutics Market Attractiveness, by Distribution Channel, 2019?2027
  • Figure 26 : Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Region2017-2027
  • Figure 27 : Global Postoperative Pain Therapeutics Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 28 : Global Postoperative Pain Therapeutics Market Attractiveness, by Region, 2019–2027
  • Figure 29 : North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,2017-2027
  • Figure 30 : North America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 31 : North America Postoperative Pain Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 32 : North America Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 33 : North America Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 34 : North America Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 35 : North America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
  • Figure 36 : North America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 37 : Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,2017-2027
  • Figure 38 : Europe Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 39 : Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 40 : Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 41 : Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 42 : Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 43 : Europe Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
  • Figure 44 : Europe Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 45 : Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,2017-2027
  • Figure 46 : Asia Pacific Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 47 : Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 48 : Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 49 : Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 50 : Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 51 : Asia Pacific Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
  • Figure 52 : Asia Pacific Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 53 : Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,2017-2027
  • Figure 54 : Latin America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
  • Figure 55 : Latin America Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 56 : Latin America Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 57 : Latin America Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 58 : Latin America Postoperative Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 59 : Latin America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
  • Figure 60 : Latin America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 61 : Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,2017-2027
  • Figure 62 : Middle East & Africa Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 63 : Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 64 : Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 65 : Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 66 : Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 67 : Middle East & Africa Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
  • Figure 68 : Middle East & Africa Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
  • Figure 69 : Mallinckrodt Pharmaceuticals, Breakdown of Net Sales, by Business Segment, 2016
  • Figure 70 : Mallinckrodt Pharmaceuticals, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 71 : Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 72 : Pfizer, Inc., Breakdown of Net Sales, by Region, 2018
  • Figure 73 : Pfizer, Inc., Breakdown of Net Sales, by Business Segment (%), 2018
  • Figure 74 : Pfizer, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 75 : Novartis AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 76 : Novartis AG, Breakdown of Net Sales (%), of Business Segment, by Region/Country, 2018
  • Figure 77 : Novartis AG, Revenue Breakdown of Net Sales (%), by Total Innovative Medicine Segment, 2018
  • Figure 78 : Novartis, AG, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 79 : Eli Lilly and Company, Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
  • Figure 80 : Eli Lilly and Company, Breakdown of Net Sales (%), by Region, 2017
  • Figure 81 : Eli Lilly and Company, Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 82 : Eli Lilly and Company, Research & Development Cost (US$ Mn), 2016 and 2017
  • Figure 83 : Teva Pharmaceutical Industries Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
  • Figure 84 : Teva Pharmaceutical Industries Ltd., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 85 : Teva Pharmaceutical Industries Ltd., Breakdown of Net Sales, by Region, 2017
  • Figure 86 : Teva Pharmaceutical Industries Ltd., Breakdown of Net Sales, by Operating Segment, 2017
  • Figure 87 : Camurus AB, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 88 : Camurus AB, Breakdown of Net Sales, by Region, 2017
  • Figure 89 : Camurus AB, Breakdown of Net Sales, by Business Segment, 2017
  • Figure 90 : Camurus AB, Research & Development Cost (US$ Mn), 2016–2017
  • Figure 91 : Bayer AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018 Figure 92: Bayer AG, Breakdown of Net Sales (%), by Region/Country, 2018
  • Figure 93 : Bayer AG, Revenue Breakdown of Net Sales (%), by Business segment, 2018
  • Figure 94 : Bayer AG, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 95 : Pacira BioSciences, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
  • Figure 96 : Pacira BioSciences, Inc., Breakdown of Net Sales (%), by Product, 2018
  • Figure 97 : Pacira BioSciences, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 98 : Trevena, Inc., Revenue (US$ Mn, 2015, 2016, 2018)
  • Figure 99 : Trevena, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 100 : Heron Therapeutics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
  • Figure 101 : Heron Therapeutics, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report